A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
University of Pittsburgh
Telix Pharmaceuticals (Innovations) Pty Limited
Instituto do Cancer do Estado de São Paulo
Memorial Sloan Kettering Cancer Center
Translational Research in Oncology
NYU Langone Health
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)